Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Feasibility Trial Using Molecular-Guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01802567
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:18.541149+00:00
Published At
2024-04-26T00:00:00+00:00
Record Updated At
2024-08-06
Results Posted At
2024-04-26
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Neuroblastoma", "Medulloblastoma", "Brain Tumors", "Rare Tumors"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-08-06"
protocolSection.identificationModule.nctId
"NCT01802567"
protocolSection.identificationModule.officialTitle
"A Feasibility Trial Using Molecular-Guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancer"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2024-04-26"

Study condition terms

  • Neuroblastoma (protocolSection.conditionsModule.conditions)
  • Medulloblastoma (protocolSection.conditionsModule.conditions)
  • Brain Tumors (protocolSection.conditionsModule.conditions)
  • Rare Tumors (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.